We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Part of unitedhealth group, inc.
Clinical Trials
0
0 active
Approvals
Total approvals
Agencies
Regulatory bodies
Founded
1984
No trial phase data available
No trial data available
No approval data available
- United Healthcare has approved reimbursement for Helius Medical's Portable Neuromodulation Stimulator (PoNS) device at $18,100, becoming the second major healthcare provider after Anthem to cover the treatment. - The PoNS device delivers neurostimulation through a mouthpiece to improve balance and gait deficits in multiple sclerosis patients, serving as an adjunct to supervised therapeutic exercise programs. - Helius Medical views this approval as validation of the clinical need and value of PoNS therapy, supporting their strategy to expand commercial payor coverage and increase patient access.
